Vaccibody AS announced a private placement of 2,255,034 shares at a price of NOK 79.07 per share for the gross proceeds of NOK 178,305,538.38 on November 23, 2021. The transaction will include participation from Regeneron Pharmaceuticals, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.37 NOK | +0.98% | -0.30% | -37.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.52% | 393M | |
-3.16% | 102B | |
+1.66% | 96.29B | |
+2.13% | 22.18B | |
-15.70% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.47% | 16.36B | |
+5.07% | 13.97B | |
+32.65% | 12.17B |
- Stock Market
- Equities
- VACC Stock
- News Nykode Therapeutics
- Vaccibody AS announced that it expects to receive NOK 178.305538 million in funding from Regeneron Pharmaceuticals, Inc.